Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07161843
PHASE2/PHASE3
Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)
Sponsor: Ebima Clifford Okundaye
View on ClinicalTrials.gov
Summary
Use of QRX-3 in hospitalized patients with pediatric and adult patients with acute tubular necrosis renal failure
Official title: Determine the Efficacy of Investigational Drug QRX-3 in Hospitalized Patients With Acute Tubular Necrosis Pattern of Acute Renal Failure
Key Details
Gender
All
Age Range
10 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
500
Start Date
2026-06-30
Completion Date
2027-02-01
Last Updated
2026-02-18
Healthy Volunteers
No
Interventions
DRUG
QRX-3
Combination of QRX-3 with standard therapy will be given to one arm in trial , another arm will receive placebo
Locations (1)
Neukidney Inc
Rosharon, Texas, United States